Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06511193

Chronicling the COPD Patient Journey and Change in COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF]

Sponsor: AstraZeneca

View on ClinicalTrials.gov

Summary

The CHRONICLES study will investigate the change in clinical and patient reported outcomes after six-months of treatment with Budenoside/Glycopyrronium/Formoterol \[BGF\] in a real-world setting.

Official title: Chronicling the COPD Patient Journey and Change in Impact of a Single Inhaler Combination Therapy on COPD Symptoms, Quality of Life and Exacerbations Following Initiation of Budenoside/Glycopyrronium/Formoterol [BGF](CHRONICLES COPD)

Key Details

Gender

All

Age Range

35 Years - 130 Years

Study Type

OBSERVATIONAL

Enrollment

152

Start Date

2024-09-17

Completion Date

2026-05-20

Last Updated

2026-02-04

Healthy Volunteers

No

Interventions

DRUG

Budenoside/Glycopyrronium/Formoterol

Patients with COPD who initiate BGF as prescribed by physician per the approved country-specific label and reimbursement criteria

Locations (1)

Research Site

Windsor, Ontario, Canada